Search for: "Sanofi Synthelabo"
Results 1 - 20
of 59
Sorted by Relevance
|
Sort by Date
16 Dec 2008, 5:16 am
Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. [read post]
9 Nov 2011, 9:59 pm
By Donald Zuhn -- In an appeal decided last month, the Federal Circuit reversed a decision by the District Court for the Southern District of New York awarding prejudgment interest to Plaintiffs-Appellees Sanofi-Aventis, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership ("Sanofi"); affirmed the District Court's denial of a motion for leave to file a supplemental answer, affirmative defenses, and… [read post]
15 Dec 2008, 9:51 pm
Sanofi-Synthelabo et al. v. [read post]
7 Nov 2008, 8:35 am
Sanofi-Synthelabo Canada Inc. [read post]
19 Jun 2007, 8:21 am
Sanofi-Synthelabo et al. v. [read post]
7 Nov 2008, 4:11 am
In a 7-0 judgment on 6 Nov 08, the Canadien Supreme Court rejected a request from Apotex Inc. to invalidate Sanofi's patent for an anti-coagulant drug (Plavix) used to combat cardiovascular degeneration.Coverage by Kirk Makin in the Globe and Mail did NOT get to the heart of this court battle involving patenting of racemates vs. patenting of enantiomers:Judge Rothstein said that in case of Sanofi's anti-coagulant drug - marketed under the name, Plavix - the company showed… [read post]
19 Jun 2007, 9:45 pm
Sanofi and BMS filed the action in March of 2002, contending that... [read post]
11 Feb 2007, 6:51 am
Atrix Laboratories, Inc. and Sanofi-Synthelabo Inc. [read post]
31 Aug 2006, 6:15 pm
Stein in Manhattan issued an injunction blocking the sale of generic Plavix ® (clopidogrel bisulfate) after a two-day hearing (Sanofi-Synthelabo v. [read post]
19 Jun 2007, 12:08 pm
Sanofi-Synthelabo v. [read post]
27 Apr 2008, 9:57 pm
In March 2002, Sanofi-Synthelabo and Bristol-Myers Squibb sued Apotex for infringing the Orange Book-listed patent, U.S. [read post]
15 Aug 2006, 6:45 am
This is the court hearing the patent infringement suit, Sanofi-Synthelabo v. [read post]
9 Nov 2017, 4:00 am
The previous Beloit precedent had used phrase “the solution taught by the patent” in its approach to obviousness, which the 2008 Supreme Court Sanofi decision had used ‘inventive concept’. [read post]
Three Strikes, You’re Out!? Apotex’s Latest Attempt to Invalidate the PLAVIX® Patent Denied by USPTO
9 Jul 2010, 3:00 am
Court of Appeals for the Federal Circuit (Sanofi-Synthelabo v. [read post]
14 Mar 2014, 1:02 pm
., Sanofi-Aventis US LLC, Sanofi-Aventis US Inc., and Sanofi-Synthelabo Inc. in a claim of strict product liability, manufacturing defect, negligence, and failure to warn. [read post]
19 Dec 2012, 8:51 pm
” Sanofi-Synthelabo v. [read post]
1 Nov 2007, 8:20 am
The studies were carried out by Pharmaceutical Products Development (PPD) on behalf of Aventis, prior to its merger with Sanofi-Synthelabo. [read post]
30 Sep 2010, 2:16 pm
Image via WikipediaBristol-Myers Squibb Co is recalling 60 million tablets of the blood pressure medication Avalide in the United States and Puerto Rico.The company said it took the action on behalf of the Bristol-Myers Squibb/Sanofi-Synthelabo partnership because of a potential variability in levels of the less-soluble form of the active ingredient in Avalide, irbesartan, which could result in slower dissolution.Bristol-Myers said 62 lots, or 60 million tablets,… [read post]
2 Nov 2009, 1:20 pm
Sanofi-Synthelabo Canada, Inc. [2008 SCC 61] The four-step approach to obviousness adopted by the Court is as follows: (1) (a) Identify the notional "person skilled in the art"; (b) Identify the relevant common general knowledge of that person; (2) Identify the inventive concept of the claim in question or if that cannot readily be done, construe it; (3) Identify what, if any, difference exists between the matter cited as forming part of the "state of the art"… [read post]
2 Jul 2007, 2:51 pm
Perrigo Plavix: Sanofi-Synthelabo et al. v. [read post]
